Not applicableActive Not RecruitingNCT05138055What this trial is testingThe NOrwegian Tick-borne Encephalitis StudyWho this might be right forTick-Borne Encephalitis, European Sykehuset Telemark 153
Large-scale testing (Phase 3)Study completedNCT00605085What this trial is testingSafety and Tolerability of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 2,675
Large-scale testing (Phase 3)Study completedNCT00595465What this trial is testingComparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 389
Early research (Phase 1)Study completedNCT00118924What this trial is testingSafety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy AdultsWho this might be right forTick-Borne Encephalitis National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableStudy completedNCT03969550What this trial is testingDo CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?Who this might be right forAIDSProgressive Multifocal Leucoencephalopathy (PML) Fondation Ophtalmologique Adolphe de Rothschild 34
Not applicableNot Yet RecruitingNCT06674837What this trial is testingDiagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis VirusWho this might be right forJapanese Encephalitis ANRS, Emerging Infectious Diseases 4,000
Not applicableStudy completedNCT04687332What this trial is testingIA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune DiseasesWho this might be right forNeurological Autoimmune Diseases University Medical Center Mainz 32
Post-approval studies (Phase 4)Study completedNCT00311441What this trial is testingStudy of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy ChildrenWho this might be right forEncephalitis, Tick-Borne Novartis 300
Post-approval studies (Phase 4)Study completedNCT01815073What this trial is testingImmunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineWho this might be right forJapanese EncephalitisChickenpox Changchun Keygen Biological Products Co., Ltd. 497
Testing effectiveness (Phase 2)Study completedNCT03204227What this trial is testingSafety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of AgeWho this might be right forJapanese Encephalitis National Institute of Hygiene and Epidemiology, Vietnam 220
Post-approval studies (Phase 4)UnknownNCT04573205What this trial is testingPrimary TBE Vaccination for the ElderlyWho this might be right forTick-borne EncephalitisVaccine Region Örebro County 90
Not applicableUnknownNCT04722328What this trial is testingEstablishment of Prevention and Control System of Central Nervous System InfectionWho this might be right forCentral Nervous System (CNS) InfectionEncephalitisMeningitis Xuanwu Hospital, Beijing 715
Post-approval studies (Phase 4)UnknownNCT04817917What this trial is testingSeroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang ProvinceWho this might be right forJapanese EncephalitisVaccine Preventable DiseaseVaccine Reaction Zhejiang Provincial Center for Disease Control and Prevention 712
Post-approval studies (Phase 4)Ended earlyNCT01211665What this trial is testingCorticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)Who this might be right forImmune Reconstitution Inflammatory SyndromeLeukoencephalopathy, Progressive Multifocal Biogen 3
Post-approval studies (Phase 4)Study completedNCT01656200What this trial is testingA Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2Who this might be right forJapanese EncephalitisJapanese Encephalitis Vaccine Indian Institute of Science 17
Large-scale testing (Phase 3)Study completedNCT01361776What this trial is testingHumoral Response to Tick-borne Encephalitis Vaccine in ElderlyWho this might be right forTick-borne Encephalitis Sormland County Council, Sweden 200
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Testing effectiveness (Phase 2)UnknownNCT00890422What this trial is testingEvaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus VaccineWho this might be right forTick Borne Encephalitis Elisabethinen Hospital 99
Testing effectiveness (Phase 2)Looking for participantsNCT06680128What this trial is testingAssess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsWho this might be right forJapanese Encephalitis Virus Disease SK Bioscience Co., Ltd. 402
Not applicableStudy completedNCT04426383What this trial is testingEvaluation of a TDM Program for Intensive Care Patients in the Cerebrospinal FluidWho this might be right forVentriculitis, Infectious Ludwig-Maximilians - University of Munich 32